US Physical Therapy Q2 FY26 net income drops 20.1% to $9.9 million; revenue rises 8.5% to $214.1 million
Reuters2026/08/05 21:59- USPh Q2 2026 net revenue rose 8.5% to $214.1 million; GAAP EPS fell to $0.25.
- GAAP net income attributable to shareholders dropped to $9.9 million; adjusted EBITDA edged up to $27 million.
- Physical therapy net revenue increased 8.4% to $182.4 million; margin narrowed 1.7 percentage points to 19.5%.
- Patient visits climbed 6.6% to 1,661,694; revenue per visit increased to $107.59 from Q2 2025.
- USPh reaffirmed full-year 2026 adjusted EBITDA guidance of $102 million-$106 million; 31 hospital-affiliated clinics integrated, 39 more slated for Q3.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hungarian Forint: Inflation surprise and HUF dynamics – ING
China’s crude oil imports in August increased by 6.2% month-on-month; refined copper and copper concentrate imports decreased by 10% year-on-year; integrated circuit export value soared by 130% year-on-year.
The core highlights of the import data are focused on the technology sector, confirming China's continued investment in critical technological fields. As tensions in the Middle East persist, crude oil imports have also rebounded, and the overseas sales of domestic refined oil products such as gasoline and diesel have increased significantly compared to July.
Crypto prices
More
